Tannishtha Reya

This study identifies that 3q-gain aneuploidy in squamous cell carcinomas creates a vulnerability to SREBP-pathway inhibition, offering a target for lipid-targeted therapies.

This study identifies Msi2 as a key regulator in lung cancer initiation and progression, showing its dual role in sensitizing cells to transformation and driving tumor growth.

This study identifies MSI2-HOXA9 as a novel oncogenic translocation driving blast crisis in myeloid leukemia, showing increased aggressiveness and mitochondrial activation.